Screener
Discontinued — last reported Q4 '21
G&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-K, filed March 9, 2022. Open the filing →
- Filed
- Mar 9, 2022, 4:16 PM EST
- Fiscal year
- FY2021
- Accession
- 0000950170-22-003229
FAQ
- What is Mirum Pharmaceuticals, Inc.'s G&A?
- Mirum Pharmaceuticals, Inc. (MIRM) reported G&A of $19.04M in Q4 2021.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Mirum Pharmaceuticals, Inc.'s g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude